DLHCX
Price
$23.49
Change
-$0.04 (-0.17%)
Updated
Oct 16 closing price
Net Assets
678.98M
JFNIX
Price
$75.38
Change
+$0.49 (+0.65%)
Updated
Oct 16 closing price
Net Assets
4.57B
Interact to see
Advertisement

DLHCX vs JFNIX

Header iconDLHCX vs JFNIX Comparison
Open Charts DLHCX vs JFNIXBanner chart's image
Macquarie Healthcare C
Price$23.49
Change-$0.04 (-0.17%)
VolumeN/A
Net Assets678.98M
Janus Henderson Global Life Sciences I
Price$75.38
Change+$0.49 (+0.65%)
VolumeN/A
Net Assets4.57B
DLHCX vs JFNIX Comparison Chart in %
View a ticker or compare two or three
VS
DLHCX vs. JFNIX commentary
Oct 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLHCX is a Hold and JFNIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 4.57B vs. DLHCX (679M). JFNIX pays higher dividends than DLHCX: JFNIX (0.38) vs DLHCX (0.00). DLHCX was incepted earlier than JFNIX: DLHCX (16 years) vs JFNIX (16 years). DLHCX (2.01) is less costly to investors than JFNIX (0.77). JFNIX is a more actively managed with annual turnover of: 35.00 vs. DLHCX (5.00). DLHCX has a lower initial minimum investment than JFNIX: DLHCX (1000) vs JFNIX (2500). JFNIX annual gain was more profitable for investors over the last year : -7.12 vs. DLHCX (-11.21). JFNIX return over 5 years is better than : 9.77 vs. DLHCX (-9.92).
DLHCXJFNIXDLHCX / JFNIX
Total Expense Ratio1.960.77255%
Annual Report Gross Expense Ratio2.010.77261%
Fund Existence16 years16 years-
Gain YTD12.15410.100120%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets679M4.57B15%
Annual Yield % from dividends0.000.38-
Returns for 1 year-11.21-7.12158%
Returns for 3 years0.3823.112%
Returns for 5 years-9.929.77-102%
Returns for 10 years21.2940.3253%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PAIGX23.04N/A
N/A
T. Rowe Price International Value Eq Adv
HSLTX50.19N/A
N/A
Hartford Small Cap Growth R5
NMSCX23.04N/A
N/A
Columbia Small Cap Index Inst
FBTDX142.67N/A
N/A
Franklin Biotechnology Discovery C
BGVCX34.75-0.07
-0.20%
Brandes Global Equity C